Cell therapies hold the promise of treating and potentially curing diseases that have long been considered untreatable. At Evotec, we are turning that promise into reality. By harnessing the remarkable versatility of induced pluripotent stem cells (iPSCs), combined with our in-house GMP manufacturing capabilities and proprietary immune-shielding technologies, we engineer next-generation immune and regenerative cell therapies designed to be safe, effective, and accessible at scale. 

Download our factsheet to learn how Evotec's iPSC platform is shaping the future of cell therapy.